stella
beta
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases — Stella
Recruiting
Back to Melanoma trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Trial locations
(1 site)
United States
Stanford University, Palo Alto, California
View full record on ClinicalTrials.gov